C World Wide Group Holding A Biomarin Pharmaceutical Inc Transaction History

C World Wide Group Holding A

  • $7.38 Billion
  • Q2 2025

A detailed history of C World Wide Group Holding A transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, C World Wide Group Holding A holds 237,851 shares of BMRN stock, worth $13.2 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
237,851
Previous 237,851 -0.0%
Holding current value
$13.2 Million
Previous $16.8 Million 22.24%
% of portfolio
0.18%
Previous 0.21%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 05, 2025
SELL
$61.25 - $72.83 $4.04 Million - $4.81 Million
-66,000 Reduced 21.72%
237,851 $16.8 Million
Q4 2023

Feb 05, 2024
BUY
$76.22 - $98.51 $3.81 Million - $4.93 Million
50,000 Added 19.7%
303,851 $29.3 Million
Q3 2023

Nov 03, 2023
BUY
$85.07 - $94.48 $3.4 Million - $3.78 Million
40,000 Added 18.7%
253,851 $22.5 Million
Q2 2021

Aug 04, 2021
BUY
$75.51 - $84.79 $3.78 Million - $4.24 Million
50,000 Added 30.52%
213,851 $17.8 Million
Q2 2019

Aug 02, 2019
BUY
$80.35 - $93.9 $7.63 Million - $8.92 Million
95,000 Added 137.98%
163,851 $14 Million
Q4 2018

Feb 12, 2019
SELL
$80.14 - $106.07 $527,321 - $697,940
-6,580 Reduced 8.72%
68,851 $5.86 Million
Q3 2018

Nov 05, 2018
BUY
$93.92 - $105.72 $1.78 Million - $2 Million
18,919 Added 33.48%
75,431 $7.32 Million
Q1 2018

May 03, 2018
SELL
$77.67 - $92.63 $13,048 - $15,561
-168 Reduced 0.3%
56,512 $4.58 Million
Q4 2017

Feb 07, 2018
SELL
$80.76 - $95.13 $2.61 Million - $3.07 Million
-32,292 Reduced 36.29%
56,680 $5.05 Million
Q3 2017

Nov 06, 2017
BUY
$80.6 - $94.95 $7.17 Million - $8.45 Million
88,972
88,972 $8.28 Million

Others Institutions Holding BMRN

# of Institutions
674
Shares Held
185M
Call Options Held
1.31M
Put Options Held
1.1M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $10.3B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track C World Wide Group Holding A Portfolio

Follow C World Wide Group Holding A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

News

Stay updated on C World Wide Group Holding A with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email